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The goal of this project is to develop an efficient methodology for extracting features from
time-dependent variables in transaction data. Transaction data is collected at varying time
intervals making feature extraction more difficult. Unsupervised representational learning
techniques are investigated, and the results compared with those from other feature engi-
neering techniques. A successful methodology provides features that improve the accuracy of
any machine learning technique. This methodology is then applied to insurance claims data
in order to find features to predict whether a patient is at risk of overdosing on opioids. This
data covers prescription, inpatient, and outpatient transactions. Features created are input
to recurrent neural networks with long short-term memory cells. Hyperparameters are found
through Bayesian optimization. Validation data features are reduced using weights from the
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1. Introduction
Opioids are an effective pain-management tool, and can be used to treat a variety of con-
ditions with great success [1]. Unfortunately, they are not always taken appropriately, and
abuse of opioids can lead to adverse, many times fatal, events [2]. Opioids are highly addic-
tive, and incorrect prescription of opioids has been a driving factor in the national increase
of overdose-related deaths in the past 20 years [3]. In 2017 alone there were over 47,000
overdose deaths in the U.S. involving opioid [4]. Of those prescribed opioids for chronic
pain, an estimated 21 - 29% misuse them and 8 - 12% develop an opioid use disorder [5]. 4
- 6% of those who misuse prescription opioids transition to heroin and 80% of heroin users
first misused opioids [6].
Over the past few years, several changes have been made to the control of prescription
opioids that have proven effective in reducing the number of fatal overdoses. The Centers
for Disease Control and Prevention released a new, more restrictive set of guidelines for
prescribing opioids [7]. This has been at the cost, however, of an over-restriction of the drug,
which is an effective pain-management tool when prescribed appropriately [8]. The opioid
epidemic has peaked, but the battle with opioids is not yet over.
1.1 Research Motivation
Much research is available concerning which populations are most vulnerable to opioid ad-
diction. Risk factors are often measured for patients by using one of many screening tools
before prescribing them opioids. These are based on multivariate statistics on the static
attributes of opioid abusers such as age and sex. It is useful to prescribers (physicians or
nurse practitioners) to create risk screening tools based on these statistical analyses. These
tools are summarized by Lawrence et al. [9].
While many doctors use screening tools before prescribing opioids to a patient, there are
not any tools available to monitor patients after treatment begins. A patient who is not
classified as vulnerable according a risk tool may become vulnerable over time. Monitoring
for patient state changes is currently done only by the prescriber based on their knowledge
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and training. There is inevitably a degree of subjectivity in their judgement. In addition,
risk tools do not include the patient’s full history of prescriptions and doctors visits. There
may patterns in a patient’s history that can be exploited to predict their risk of addiction
on an individual basis.
Many datasets have been underutilized in combating the opioid epidemic from a data
perspective. These include Electronic Health Records (EHR), Prescription Drug Monitoring
Programs (PDMP), and Insurance Claims data, all of which are transaction datasets. Trans-
action data can be defined as any temporal sequence where a number of entities are recorded
performing different events. Transaction data is much more utilized in areas other than
healthcare, but more research is needed in order to improve usability. In the field of data
mining, association rules and sequence matching have been the target of most algorithms
utilizing transaction data [10]. Extraction of more informative features to use in prediction
models is still a budding research area [11].
Research has been done to predict other medical responses fully utilizing this type of
transaction data, but there is a dearth of research using similar methodologies for opioid-
related responses. Many times in the medical field, features are created using expert knowl-
edge. While this does not yield bad predictions, better may be obtained by exploited the
full complexity of the data. Time-dependent features created are usually relegated to small
window of the entire data. In addition, features are only created using variables of interest.
There may be complexities in the data that are not known to be related to the response
in the medical literature. Fully utilizing the time-dependent aspect of the data will allow
complex interactions in the data to be exploited for better predictions.
1.2 Research Goals
The goals of this research are to (1) develop a framework for feature extraction from transac-
tion data, (2) explore deep learning techniques using those extracted features for predicting
patients as at risk of adverse, opioid-related events (ORE).
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These goals will be accomplished through experimenting with various strategies trans-
forming raw data into usable features in combination with different modeling strategies.
This research focuses on deep learning techniques for both feature extraction and prediction.
The best combination of techniques found will be used to develop a framework for feature
extraction and prediction using transaction data.
1.3 Thesis Organization
Chapter 2 begins with a review of literature related to the prediction of ORE for individual
patients. These include studies that use both point-in-time, or cross-sectional data, as well as
those using time-dependent, or panel data. The application of the methodologies developed
in these studies is then discussed.
The literature review continues with studies related to prediction of events from transac-
tion data that use feature extraction and deep learning techniques. Although studies using
healthcare-related data are primarily looked at, studies using data from other fields are in-
vestigated as well. The focus is on prediction using machine learning and deep learning
techniques, as well as feature extraction.
Chapter 3 describes the methodology for data processing, feature extraction, and predic-
tion. The data subsection includes data sources, cohort selection, response identification, as
well as transformations used to prepare the data as an input to train different models. Trans-
formation is especially important due to the research goal of extracting appropriate features
from the data. In order to get the most informative features, different time aggregation
windows with varying sequence lengths are tested
Prediction methodology begins with using those extracted features in a recurrent neural
network with long short-term memory cells to predict ORE. Hyperparameters of each model
are tuned using Bayesian optimization. To improve predictions, autoencoders are used to
find better representations of the original inputs. Features from the autoencoders are then
input into several different prediction models for comparison. These are compared to using
the learned weights from the neural networks as input for the same models.
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Results are presented, compared, and discussed. Also discussed are potential applications
of this methodology, medical implications of the results, and limitations of this research.
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2. Literature Review
This chapter focuses on a review of the methodology used in this research. The first section
of this chapter covers previous work related to the prediction of ORE from transaction
data. These works are divided by prediction methodology and data source. The second
section covers the methodologies used in this research. It begins with a description of deep
learning and continues to describe research using deep learning models with healthcare-
related transaction data. Finally, research using representational learning to better represent
healthcare data is discussed.
2.1 Prediction of Opioid-Related Adverse Events
EHR, PDMP, and Claims data have all been used with varying degrees of success to predict
the risk of a patient of having an opioid-related adverse event. Methodologies for prediction
patient-level adverse events range from simple statistical tests to advanced deep learning
techniques. The following review is broken up by the primary prediction methodology used
in each study.
Logistic regression (LR) is a very popular methodology in the literature and has been
applied to many different datasets for ORE prediction as reviewed by Turk et al. [12]. The
value of LR lies in its explanatory power. In these papers, the primary use of the model is to
learn which variables are most related to a positive response as opposed to predicting which
patients will have an ORE.
The Cox proportional hazards (CPH) model is one of the most predominately used models
in individualized patient predictions. The model is in essence a regression of survival time on
the patient variables. Its popularity is also due to the explanatory nature of the model. For
each feature used to build the model, the proportional likelihood that the level of that feature
will correspond to a response is calculated. Several papers have used this methodology to
predict adverse events related to opioids.
Decision trees are another popular classifier. Both the random forest (RF) and gradient
boosting (GB) algorithms have been used for ORE prediction. Neural networks (NN) have
5
also been used, and these are detailed in the next section. A summary of ORE prediction
literature is shown below in Table 1.
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2.2 Introduction to Deep Learning
Deep Learning is a catch-all term used to describe many different types of neural networks.
This section provides a brief description of the way neural networks are constructed and
trained. For further reading, please refer to Deep Learning by Goodfellow et al. [11]. A
neural network, at its essence, is simple a graph of nodes and weights used to transform an
input to a desired output. They are usually structured with layers of nodes so that every
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node in one layer is connected to every node in the layers on either side. The connections
between these nodes have are a assigned a weight that changes in as the network is trained.
Training a neural network begins with initializing the weights. This is most typically done
using random values from a normal distribution, but sometimes different functions are used.
The inputs are then passed through the graph. At each node, the input is passed through
an activation function that adds some nonlinearity. The most commonly used activation
function is the sigmoid function. These are prone to forcing values to become either really
big of really small in large networks, or what is commonly known as the vanishing and
exploding gradient problem. Using a rectified linear unit (ReLU) activation has recently
gained popularity to mitigate this issue. As values pass from node to node they are multiplied
by the weights between those nodes. At the last layer, the output layer, the values are
compared to the desired output using some loss function. The loss function measures the
difference between the original input and the network output. The goal is to minimize that
different for all training examples.
The weights of the network are adjusted to decrease the value of the loss function through
a process known as backpropagation. To do this, the first derivative of the loss function is
taken with respect to each of the output nodes. The derivative of each of those function
is taken with respect to each of the nodes connected to that node from the previous layer.
Then for each of those nodes, the process is repeated again until the first derivative is found
for all possible paths through the graph. The weights between each node are adjusted using
the corresponding derivative of the loss function so that the value of the loss function is
decreased. How much the weights get adjusted each iteration is referred to as the learning
rate.
Different optimizers perform backpropagation in different ways. Gradient descent is the
easiest to understand. In order to minimize the loss function, we simply want to find the
gradient (or first derivative with respect to each variable) that decreases the function the
fastest. However, this approach is susceptible to getting stuck in local minimums. Local
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minimums are relatively low compared to the surrounding points, but not the lowest point
the loss function can be in general. An alternative, stochastic gradient descent, adds an
element of randomness to the search in order to avoid the local minimum issue. The most
popular algorithm to use in deep learning research is the Adam optimizer. It takes less time
to train than stochastic gradient descent while achieving similar performance.
The forward and back propagation process is done for each observation in the training
data. One pass through all observations is referred to as an epoch. Networks are trained
using several epochs until performance is deemed adequate or shows no sign of improvement.
To speed up training, batches of observations are used to train. A batch of observations are
forward propagated through the network and the average of the loss function calculated for
the entire batch before performing backpropagation.
2.3 Individualized Healthcare Predictions Using Deep Learning
Neural networks are used in many other healthcare-related event predictions besides OREs.
The most relevant to this research are those which utilize to the most extent a similar type
of transaction type data. By utilizing the temporal nature of this type of data, the following
studies were able to make much better predictions than those predicting based on static
features. They also make use of the entirety of information available in the data by using
representational learning techniques.
2.3.1 Types of Networks Used
There are many different approaches to take when trying to classify patients. Neural networks
have the most potential according to the literature, so we focus on investigating them [31].
Neural networks have been around for a very long time, but only in the last decade become
popular due to increased computing power and data collected. The basic concept of neural
networks is briefly explained in this section
The most basic type of a neural network is the feed-forward neural network (FNN).
They are composed of an input layer (X), hidden layers (h), and an output layer (y) shown
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below in Figure 1. Every cell is connected to every cell in the next layer. The weights for
these connections are trained based on the gradient of the loss function, a process called
back-propagation. Non-linearities are introduced in each cell by an activation function [11].
Figure 1. A two-layer FNN with one output
Recurrent Neural Networks (RNNs) are more effective to use in making predictions based
on sequential inputs[32]. Unlike FNNs, they accept a sequence of inputs for each observation
where information from past sequence elements is incorporated into each cell. The structure
of a RNN with two layers of recurrent cells is illustrated in Figure 2. In the figure, X is the
input sequence, h is a dense hidden layer, y is the output, and A are the recurrent cells. They
are widely used in natural language processing tasks, but can be applied to any sequential
data as they are designed to deal with long-range temporal dependencies [33].
10
Figure 2. Structure of an RNN with two layers of recurrent cells
Training ordinary RNNs is difficult as they are prone to both vanishing and exploding
gradients, but this can be remedied by using gates to restrict how much information gets
passed from cell to cell [34]. There are two popular types of gated RNNs, those using gated
recurrent units (GRU) [35] and those using long short-term memory cells (LSTM) [36]. The
difference between the two lies in the number of gates and the exact purpose they serve.
While LSTM networks have proved more effective for natural language processing tasks,
GRU networks are computationally more efficient while providing comparable results [35].
Deep learning models have many hyperparameters that must be tuned. Grid search and
random grid search are typically used, but Bayesian optimization can be used to fine the
best combinations of hyperparameters in a more efficiently [37], [38].
2.3.2 Deep Learning for ORE Prediction
The most promising methodology in ORE prediction is deep learning. Deep learning refers
to the use of neural networks with more than one hidden layer. The advantage of deep
learning models is their ability to learn representations of the data with multiple levels of
abstraction. The multiple hidden layers allow the model to discover complex interactions
that exist between variables [32].
Che et al. [30] used both FNN and LSTM to classify patients in the Rochester Epi-
demiology Project (n=102,166) as either short-term, long-term, or opioid-dependent users.
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To prepare the temporal data, they used one-hot encoding to categorical features and ag-
gregated by year. They found FNN to predict better than RNN, with 90% accuracy and
62% recall. This research will use a similar approach but with more granular time windows.
Another difference will be the response of ORE instead of opioid dependence.
Claims data (n=186,686) was used by Lo-Ciganic et al. [24] along with logistic regression,
random forest, gradient booting machine, and feed-forward neural network to predict the
risk of ORE. The neural network had the best performance of any model. They used 3 month
time windows instead of the more granular windows used in this study. In addition, features
were developed based on domain instead of the more naive approach of this research.
2.3.3 Other Deep Learning Uses in Healthcare Prediction
Choi et al. [39] used GRU to predict different diagnoses based on EHR data (n=263,706).
The model was trained on the sequence of patient visits with all corresponding information
one-hot encoded. They were able to achieve 79% recall and 64% accuracy with this model.
This work was later extended [40] by using fixed-sized time windows which aggregated events
instead of using events themselves to predict the occurrence of heart failure using a similar
EHR dataset. Esteban et al. [41] used a novel structure to incorporate static features
into an RNN network that reduced the dimensionality of the input. They found that a
GRU network outperformed LSTM and ordinary RNN networks in predicting outcomes
from kidney transplants using EHR data.
Nickerson et al. [42] predicted the occurrence of adverse post-operative events from
time-window aggregated EHR data using both FNN and LSTM networks. The DeepCare
framework proposed by Pham et al. [43] uses the sequence of admissions recorded in EHR
data, classified into diagnosis events and intervention events, in an LSTM network. Several
modifications to the traditional LSTM network were made, and in different experiments
they predicted both diabetes and mental health related outcomes with a relatively high F-
score. Razavian et al. [44] trained a LSTM on the results of lab tests recorded in claims
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data (n=298,000) in order to predict the onset of 133 different diseases. To deal with class
imbalance, they use a weighted log-likelihood function with changing weights for each batch.
LSTM cells were used by Lipton et al. [45] to predict the occurrence of any of 128
different diagnoses using irregularly sampled tests in EHR data from an intensive care unit.
They found LSTM outperformed other models, including FNN. Their best performing model
utilized an ensemble of LSTM and FNN networks. Puruchotham et al. [46] compared
different machine learning models on a publicly available EHR dataset. They also found
that an ensemble model of FNN for static features and RNN for time dependent features
consistently yielded the best predictions.
2.3.4 Methods of Information Extraction
Many machine learning techniques have a limited ability to utilize raw data. Prepossessing to
transform the raw data usually requires domain experts to manually engineer usable features.
Representational learning is a set of methods that automatically learn usable features from
the data. Deep learning methods of representational learning allow for complex functions to
be learned from the raw data, with no domain expertise needed [32].
The DeepCare algorithm developed by Pham et al. [43] involves pooling same type
features over time windows and then concatenating the different feature vectors. In this way
they embed variable number of events into a continuous distributed vector space.
Skip-gram embeddings are a popular preprocessing technique for natural language pro-
cessing tasks popularized by Mikolov et al. [47]. E. Choi et al. used skip-gram representations
of different medical codes assigned to each patients as an input to an RNN [48], [49], [40]. Y.
Choi et al. used skip-gram embedding on several different data and found that in all cases
the results conceptual similarity and medical readiness of the data was improved [50].
Autoencoders (AEs) were used by Miotto et al. [51] to improve the performance of their
prediction model. The best AE structure for their data was using three hidden layers with 500
nodes each. The advantage of AEs over standard dimensionality reduction techniques such
13
as principal component analysis or singular value decomposition is their ability to capture
complex interactions between variables [33].
AEs are not the only way to develop better features with deep learning. Che et al. [52]
proposed a framework for feature extraction from heterogeneous healthcare time series data
using a form of greedy layerwise pretraining. This methodology, similar to that proposed
by Bengio et al. [53], increases the performance of a deep network by training a model with
one hidden layer, then adding a layer at a time, retraining the weights learned in the last
iteration.
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3. Data Processing and Prediction Methodology
This chapter begins by describing the data used, the cohort selection process, and the meth-
ods by which the data was cleaned and transformed. The data were divided into 20 distinct
datasets for experiments. Each of these datasets was used to train a RF classifier, a sparse
AE whose features were then used to train a RF classifier, and a RNN with LSTM cells.
For the LSTM models, hyperparameter tuning was done using Bayesian optimization. A
simple, denoising, and sparse AE was trained on each dataset and outputs used to train
other classifiers. This research utilizes Tensorflow [54], an open-source tool for applying
machine learning methodologies, using Keras [55]. All data preprocessing was completed
using Python with pandas [56] and NumPy [57]. Classifiers from Scikit-learn [58] are used to
compare models. Bayesian optimization for hyperparameter tuning was accomplished using
GPyOpt [59].
3.1 Introduction to Data and Data Processing
This section describes the dataset used and the processing techniques to transform it. Data
preprocessing is as important as, if not more important than, the prediction models tested,
since the results from the models can only be as good as the data used to train them.
Transaction data can be tricky to use effectively in machine learning. This section lays out
a framework to use transaction data to construct inputs to any classification or regression
tool.
3.1.1 Data Description
The LifeLink PharMetrics Plus database is used in this research. It contains inpatient,
outpatient, and pharmacy (RX) claims for millions of unique patients enrolled in major
healthcare insurance plans from 2006 to 2015. Of these patients, approximately 2.6 million
received at least one opioid prescription during this time frame.
3.1.2 Patient Cohort and Response Identification
The same criteria developed by Li et al. [28] was used for selecting the cohort of patients.
The cohort are those who receive their first recent opioid prescription while covered in our
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dataset. The first opioid prescription for each patient is considered the index claim. Patients
with no opioid prescriptions are excluded. We only consider patients who are continuously
enrolled in the insurance plan 6 months before and after the index claim. Patients with
cancer or in hospice care, as well as patients younger than 13 are excluded as well. The
cohort consists of 1,376,760 patients. Those patients average 134.27 events recorded after
their first opioid prescription over the course of 688.78 days. The largest gap between the
first opioid prescription and the last event was 3464 days with 9004 events in between.
The response, OREs, are identified using ICD-9 diagnoses codes. Modeled after one of
the responses used by Seal et al. [60], a patient diagnosed with one of the codes shown
in Table 2 is considered to be a positive response for ORE. This differs in the response
identified by Li et al. [28] by not considering patients who are only coded with a respiratory
depression diagnosis. The narrower definition will yield fewer false positives at the risk of
missing some OREs experienced by patients. There are 1,533 patients who exhibit an ORE
by this definition in the cohort.
Table 2. ICD-9 Codes Identifying ORE
ICD-9 Code Description
965 Poisoning by opium (alkaloids), unspecified
965.02 Poisoning by methadone
965.09 Poisoning by other opiates and related narcotics
E850.1 Accidental poisoning by methadone
E850.2 Accidental poisoning by other opiates and related narcotics
E935.1 Methadone causing adverse effects in therapeutic use
E935.2 Other opiates and related narcotics causing adverse effects in therapeutic use
3.1.3 Combining Data Sources
Inpatient, outpatient, and RX claims are recorded in separate tables, each having a distinct
set of associated variables. There also exists a table of patient information. These tables are
structured as a relational database where each table of events is connected to the patients
table by a unique identifier. This research considers each event (claim or transaction), as
an observation for a patient. As such, events in the inpatient, outpatient, and RX tables
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were all combined into one table of events. Static patient information was added to this
table of events as well. The tables had some overlapping variables. The final variables used
for modeling are shown in Table 3. The three event tables (inpatient, outpatient, and RX)
were appended together with respect to the variables they shared as shown in Figure 3. In
total, they consist of 184,852,600 events. Labels across the top of the figure are the sets of
variables included in the tables. A categorical variable indicating the source table of each
event was added which is not shown.
Figure 3. Combining Sources of Events
3.1.4 Data Cleaning and Preprocessing
For the selected cohort of patients, there were a few variables that were no longer needed
to be included. Several were removed because there was no variation throughout between
patients. For example, one variable indicated whether the claim was paid for or denied. For
the given cohort every claim was paid for, so this variable was removed. Other variables
with very low response rate or high redundancy with other variables were removed as well.
For the categorical variables remaining, many had a large number of categories that a very
small proportion of the events fell into. These categories were recoded so that any category
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containing less than 1% of events were grouped into an "other" category. This was done to
reduce dimensionality once one-hot encoded. Continuous variables, shown in Table 3, were
scaled between 0 and 1. Scaling continuous variables is a common preprocessing step that
helps avoid vanishing and exploding gradient problems [61].
Diagnosis and procedure codes for inpatient and outpatient events are both very impor-
tant to a patient’s history. They contain all information about conditions a patient was
diagnosed with and how they were treated. There are up to 11 supplementary diagnosis
codes in addition to the diagnosis code for admission. There are up to 6 procedure codes for
each event. In this data, both procedures and diagnoses are coded using the ICD-9 conven-
tion. According to this condition, there are over 15,000 possible diagnosis codes and nearly
4,000 procedure codes. If these original variables were one-hot encoded it would result in
more than 204,000 columns!
In order to reduce the high dimensionality of the ICD-9 code combinations, we used
the Agency for Healthcare Research and Quality’s Healthcare Cost and Utilization Project
(HCUP) clinical classification software (CCS). This software classifies ICD-9 codes into a
smaller number of categories. Diagnosis codes are mapped to 285 categories, and procedure
codes to 232. The HCUP’s chronic condition indicator (CCI) was also used for diagnosis
codes. This is a binary variable indicating whether a diagnosis is chronic or not. HCUP’s
procedure classes (PC) code was added as well to indicate the severity of the procedure
preformed, of which there are four categories. After recoding each of the 12 diagnosis code
columns in 2 ways (CCS and CCI) and and 6 procedure code columns in 2 ways (CCS and
PC), each of the 36 new columns were one-hot encoded. Columns for similar categories
were then summed for each event to reduce the sparsity of the data since it does not matter
which diagnosis column a diagnosis was recorded in, just that the diagnosis occurred for
that event. This resulted in adding 523 columns for diagnosis and procedure codes instead
of 204,000. 1010 total features resulted from data preprocessing after one-hot encoding
categorical variables.
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Table 3. Variable Descriptions
Variable
Type
Variable Data Type Number of
Categories
Patient Age at first opioid claim Continuous
Group or individual coverage Categorical 3
Sex Categorical 3
Enrollee relationship to patient Categorical 6
State Categorical 51
Event Event type Categorical 3
Days after first opioid prescription Continuous
Provider type flag Categorical 3
Billing provider’s primary specialty Categorical 65
Rendering provider’s primary specialty Categorical 65
Place of service code Categorical 9
RX Days of supply of the prescription Continuous
Drug Group (first two digits and first subset of
the GPI code) classifies general drug products
Categorical 69
Brand is trademark or generic Categorical 2
Prescriber’s primary specialty Categorical 63
Dispensed as written code indicating whether
or not the prescriber’s instructions regarding
generic substitution were followed
Categorical 4
Route of administration - how the medication’s
dosage form is administered to the patient
Categorical 7
Whether the prescription drug was paid as in-
cluded in the plan’s formulary at the record
level
Categorical 2




Admitting diagnosis; ICD-9 diagnosis patient
was admitted with
Categorical ~15,000
Diagnosis codes 1–11; ICD-9 diagnosis codes of
the event
Categorical ~15,000
Procedure codes 1–6; ICD-9 procedure codes of
the event
Categorical ~4,000
Specialty of the attending provider. For
non-physicians, this reflects the type of
provider/facility
Categorical 56
Specialty of the primary care physician Categorical 43
Inpatient
Only
Length of stay (only for inpatient events) Continuous
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3.1.5 Transforming the Data to Inputs
There are multiple ways to transform our original dataset into features for prediction. The
simplest way is to strictly consider a patient’s transaction history as a sequence of events.
This is already how the data is structured, with each transaction (event) having a number
of descriptive variables. The other approach is to aggregate the sequence of events over time
windows. This strategy essentially collapses the events into one observation for each time
window. Time windows could be of either fixed or variable length, but for simplicity of
replication with other data, this study only uses fixed-length time windows. Each patient’s
set of time windows ends the day before the last non-ORE event in their event sequence.
Time aggregates are calculated for each monthly, bi-weekly, weekly, and daily windows.
Aggregates are found by summing both continuous variables and one-hot encoded categorical
variables over each time window. One-hot encoded categorical variables are then clipped to
be either 0 or 1. Clipping categorical variables reduces the amount of redundant information
in the data. For example, consider a patient who has three outpatient events during a time
window and receives the same diagnosis all three times. Once the patient has been diag-
nosed with a condition during the time window, subsequent diagnoses of the same condition
should not matter. The one-hot encoded variable indicating source table (RX, Inpatient,
Outpatient) was not clipped after aggregating in order to inform the model of the number of
event transpiring during the time window. For example, it would be important information
to know if a patient went to the pharmacy 10 times in a month. Static variables about
the patient remain the same with aggregation. If a patient had no events occur during a
time window, those variables are filled with 0s. There are 5 datasets being investigated:
time window aggregates of monthly, bi-weekly, weekly, and daily events, as well as using the
events with no aggregation.
The length of the sequence used in prediction is also important to consider. The sequence
of data for every patient must be the same length. Events occurring closer to the ORE re-
sponse are hypothesized to have more influence on the ORE than those events occurring
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farther in the past. For this reason, the sequences are aligned by the last event for each pa-
tient, the event directly preceding an ORE for positive responses and the last event recorded
for negative responses. Then, the sequence is trimmed to the desired length from the left,
excluding the earlier events for patients with sequences longer than that length. This process
is illustrated in Figure 4 below, where the sequence length is chose to be 4. Patients with
less than 4 events are excluded. For each of time aggregate datasets, only patients having
events covering the entire time window will be included in the dataset for that time window.
In this experiment, sequence lengths of 5, 10, 20, and 40 observations were tested. These
lengths were chosen to encompass a broad range of sequence lengths. Combining these with
the 5 time aggregation methods yields a total of 20 sets of data to test.
Figure 4. Visualization of Sequence Alignment and Trimming
Only transactions recorded on the day of or after the date of a patient’s first opioid
prescription are used. The transactions of patients with an ORE are only included up until
the day before the first ORE identified. All transactions of patients without an ORE are
included. Transactions are also only included for a patient’s continuous enrollment period.
That is, if the patient becomes dis-enrolled from the insurance plan, transactions after that
time are excluded from the data.
3.1.6 Batch Processing
Given the large size of this data, special techniques had to be used for processing. There are
over 184 million rows of 1010 columns in the final dataset. That is 185 billion data points.
This is way to much data to be held in memory so a data chunking technique was used for
processing. Data was queried in chunks from the combined events table, taking care not to
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break a patient’s data between chunks. Events for each patient were cropped to the specified
sequence length. The min and max of continuous columns were updated and the data chunk
stored in hdf5 format [62]. After the query was complete, each chunk was then reopened for
processing. Continuous variables were scaled between zero and one and categorical variables
were one hot encoded. All possible categories for each categorical column were hard coded
so that each chunk would be one hot encoded to the same number of columns. The events
for each patient were then aggregated for each time window as described in the previous
subsection. Time windows with no events were filled with zeros.
3.2 Deep Learning
Each dataset is split into train, validation, and testing sets. First, a random 20% of the data
was selected as the test set. The remaining data was split 80% training and 20% validation
as shown in Figure 5. For each split, the data was stratified so that the same proportion of
ORE patients where in each set.
In order to see how well different models work, we must start out with a simple model
to get a baseline for prediction. Random forest was chosen due to its popularity of use in
medical research [25], [29]. RNNs with LSTM cells were then trained for each dataset. The
hyperparameters of each model are found using Bayesian optimization and the validation
data. Models are then trained on both training and validation data and tested on the
remaining testing data. A sparse AEs was trained, and the outputs fed into the same
baseline model.
Figure 5. Visualization of Training, Validation, and Testing Split
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Given the size of the data, it cannot be all kept in memory. Neural networks can be
trained online and do not need to be input all the data at once. The other classifiers used
are not online and all training data must be loaded into memory at one time. It is not possible
to train on the entire dataset due to computational limitations. Classifiers are trained on
the validation data, 16% of the entire dataset, and tested on the same holdout testing data,
20% of the entire dataset. This is done 5 times, each with a different portion of the training
data so that all training observations are using in training a model.
3.2.1 Models Tested
RNN with LSTM cells will were tested using all 20 datasets. A basic structure of two layers of
recurrent nodes and two layers of dense nodes was chosen. This number of layers was chosen
because having more hidden layers allows the model to learn higher level abstractions from
the input data [11].
To train the RNN, we used log loss, otherwise known as binary cross-entropy in Keras.
Since the data is incredibly imbalanced, class weighting was used to weight the loss function
[63]. Rectified linear unit (ReLU) activation functions were used as it reduced the exploding
and vanishing gradient problem [11]. Dropout method was used to help prevent overfitting
of the training data [64], [65]. Batch normalization is used as well [66].
Good combinations of hyperparameters for training with each dataset were found using
Bayesian optimization [37], [38], [67]. Hyperparameters considered were the number of nodes
in each layer, dropout rate of each layer, learning rate, batch size, and number of epochs to
train for. The model is trained using the training set and tuned using the validation set in
each iteration of the algorithm. Once the best hyperparameters are found, they are used to
train the model on both the training and validation set and tested with the testing set that
was held out.
The output of each model comes from a sigmoid function and is between 0 and 1. The
threshold for which the model classifies an observation as either positive or negative is very
important. For each model, the threshold that maximizes weighted accuracy metric is used
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to determine the final model. Mathews correlation coefficient [68] was also considered as a
metric to maximize.
3.2.2 Representation Learning
The raw inputs to the models listed above should produce fairly well performing classifiers
due to the size of the raw input and the power of neural networks to find hidden dependencies
in the data. The goal, however, is to create features that can be used in other classifiers that
will achieve an even better performance.
Supervised representation is where observation labels are used to help create the features.
One supervised feature representation technique is to use the learned weights from a neural
network. After the network is trained, the prediction layer is removed and the outputs from
the last hidden layer are used as the new features.
A similar unsupervised feature representation technique is to use AEs [69]. These are
neural networks that are designed to encode information from the input to a lower dimension.
The simplest versions have one hidden layer, but deep AEs with multiple hidden layers may
be more effective. AEs can be stacked, oftentimes making them more effective [70]. The
method of training stacked AEs, greedy layerwise unsupervised pretraining, is very similar to
greedy layerwise supervised pretraining in that each layer of the AE is trained with weights
initialized as the weights learned from training the previous layer. Unsupervised feature
representation yields better results in many cases [71].
In this research, we train a sparse AE using each dataset. A sparse AE with 5 layers is
used to find higher level abstractions in the data. These five layers consist of 1250, 2500,
5000, 2500, and 1250 nodes respectively. Its output has the same dimension as the original
data. Our loss function to train the sparse AE is mean squared error between the inputs




The number of patients in each of the datasets tested is shown below in Table 4. These differ
because of the exclusion criteria applied when creating different datasets. Patients whose
sequence of events is not as long as the sequence length are excluded. Patients who have no
events recorded during that time window are also excluded.
Table 4. Size of Dataset Used
Sequence Length
Time Aggregate 5 10 20 40
Events 1,265,087 1,309,926 1,207,803 1,005,234
Days 302,643 481,942 684,805 955,942
Weeks 904,586 1,081,934 1,205,549 1,259,576
Bi-Weeks 1,081,934 1,205,549 1,259,576 1,198,651
Months 1,213,888 1,260,371 1,183,033 879,132
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4.2 Random Forest Classifier
Random forest classifiers were trained as a baseline for comparison. For each dataset, 5 mod-
els where trained using different portions of the training set. Average results models trained
using each dataset are shown in Table 5. This methodology had a relatively high accuracy
and area under the receiver operating characteristic curve (AUC). For most datasets, recall
was poor.
Table 5. Random Forest Classifier Results
Time Aggregate Sequence Length Accuracy Recall Precision AUC
Events 5 0.718 0.733 0.002 0.725
Events 10 0.783 0.483 0.003 0.633
Events 20 0.781 0.395 0.003 0.588
Events 40 0.702 0.392 0.002 0.547
Days 5 0.638 0.417 0.004 0.527
Days 10 0.592 0.503 0.003 0.548
Days 20 0.805 0.303 0.003 0.555
Days 40 0.854 0.261 0.002 0.558
Weeks 5 0.755 0.477 0.003 0.616
Weeks 10 0.781 0.405 0.002 0.593
Weeks 20 0.717 0.418 0.002 0.568
Weeks 40 0.762 0.373 0.002 0.567
Bi-Weeks 5 0.76 0.424 0.002 0.592
Bi-Weeks 10 0.789 0.355 0.002 0.572
Bi-Weeks 20 0.764 0.361 0.002 0.563
Bi-Weeks 40 0.741 0.409 0.001 0.575
Months 5 0.765 0.437 0.002 0.601
Months 10 0.837 0.28 0.002 0.559
Months 20 0.701 0.443 0.001 0.572
Months 40 0.815 0.258 0.001 0.537
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4.3 Sparse Autoencoder
An AE that expands the input to 5000 nodes in order to uncover abstractions is trained.
The output was fed into a random forest classifier. Results are shown below in Table 6.
For each dataset, this methodology performed worse than the baseline classifier. This is a
substantially worse methodology than only using RF.
Table 6. Random Forest using Sparse AE with 5000 nodes
Time Aggregate Sequence Length Accuracy Recall Precision AUC
Events 5 0.903 0.416 0.003 0.66
Events 10 0.941 0.343 0.006 0.643
Events 20 0.966 0.212 0.007 0.589
Days 5 0.919 0.104 0.003 0.513
Days 10 0.893 0.133 0.003 0.514
Days 20 0.827 0.229 0.002 0.529
Weeks 5 0.913 0.189 0.003 0.552
Weeks 10 0.973 0.092 0.004 0.533
Weeks 20 0.986 0.048 0.004 0.518
Bi-Weeks 5 0.986 0.046 0.004 0.517
Bi-Weeks 10 0.989 0.019 0.002 0.505
Bi-Weeks 20 0.991 0.024 0.003 0.508
Months 5 0.961 0.093 0.003 0.528
Months 10 0.983 0.024 0.001 0.504
Months 20 0.991 0.015 0.002 0.503
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4.4 LSTM RNN Predictions
Before performing Bayesian Optimization to tune the hyperparameters, arbitrary hyperpa-
rameters were chosen to see how well the tuning improved training the models. The dropout
rate parameter was set to 0 and 0.2 for the two recurrent layers, respectively, and 0.1 for
the dense layer. There were 128 nodes in the recurrent layers and 64 nodes in the dense
layer. Batch size of 500 with a learning rate of 0.001 was used to train the each model for
10 epochs. The results are shown below in Table 7.
Table 7. LSTM Classifier Before Tuning Hyperparameters
Time Aggregate Sequence Length Accuracy Recall Precision AUC
Events 5 0.895 0.571 0.003 0.839
Events 10 0.795 0.819 0.004 0.869
Events 20 0.857 0.723 0.005 0.857
Events 40 0.337 0.796 0.001 0.566
Days 5 0.412 0.896 0.004 0.753
Days 10 0.514 0.774 0.003 0.698
Days 20 0.437 0.805 0.002 0.675
Days 40 0.001 1 0.001 0.5
Weeks 5 0.725 0.716 0.003 0.792
Weeks 10 0.809 0.637 0.004 0.763
Weeks 20 0.775 0.603 0.003 0.731
Weeks 40 0.849 0.553 0.004 0.752
Bi-Weeks 5 0.778 0.625 0.003 0.752
Bi-Weeks 10 0.872 0.532 0.005 0.74
Bi-Weeks 20 0.835 0.545 0.003 0.722
Bi-Weeks 40 0.999 0 0 0.5
Months 5 0.842 0.532 0.004 0.733
Months 10 0.84 0.538 0.003 0.757
Months 20 0.872 0.522 0.004 0.742
Months 40 0.839 0.5 0.002 0.715
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Using the best hyperparameters found from 25 iterations of Bayesian optimization, a
model is trained using the both the training and validation data, and tested using the
holdout set. Results from selected models are shown below in Table 8.
Table 8. LSTM Classifier After Tuning Hyperparameters
Time Aggregate Sequence Length Accuracy Recall Precision AUC
Events 5 0.854 0.652 0.003 0.822
Events 10 0.999 0 0 0.303
Events 20 0.793 0.788 0.004 0.823
Events 40 0.999 0 0 0.5
Days 5 0.187 0.993 0.003 0.712
Days 10 0.075 0.979 0.002 0.409
Days 20 0.003 1 0.002 0.579
Days 40 0.023 0.984 0.001 0.514
Weeks 5 0.187 0.872 0.001 0.531
Weeks 10 0.001 1 0.001 0.331
Weeks 20 0.001 1 0.001 0.5
Weeks 40 0.999 0 0 0.5
Bi-Weeks 5 0.701 0.683 0.003 0.758
Bi-Weeks 10 0.806 0.58 0.003 0.707
Bi-Weeks 20 0.846 0.518 0.003 0.722
Bi-Weeks 40 0.999 0 0 0.5
Months 5 0.735 0.632 0.003 0.728
Months 10 0.905 0.369 0.004 0.67
Months 20 0.999 0 0 0.5
Months 40 0.999 0 0 0.5
The 10 best RNN models are summarized below in Table 9. Around half of these models
were trained using the baseline hyperparameters as opposed to those found through Bayesian
optimization hyperparameter tuning. The AUC for most of the datasets is much higher than
the baseline model. The smaller sequence lengths did better for most of the datasets. The
only dataset that was not time-aggregated performed the best as well.
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Table 9. Comparison of the best LSTM Models
Time Aggregate Sequence Length Accuracy Recall Precision AUC
Events 10 0.795 0.819 0.004 0.869
Events 20 0.857 0.723 0.005 0.857
Events 5 0.895 0.571 0.003 0.839
Weeks 5 0.725 0.716 0.003 0.792
Weeks 10 0.809 0.637 0.004 0.763
Bi-Weeks 5 0.701 0.683 0.003 0.758
Months 10 0.84 0.538 0.003 0.757
Days 5 0.412 0.896 0.004 0.753
Weeks 40 0.849 0.553 0.004 0.752
Months 20 0.872 0.522 0.004 0.742
4.5 Comparison of Classifier Results
The recall and accuracy of all models is plotted below in Figure 6. It is easy to see from this
graph that LSTM RNNs give the best balance between accuracy and recall out of the three
methodologies tested. It is most important to have a high recall in order to not miss many
patients who are at risk of experiencing of experiencing an ORE. It is clear that LSTM is
the best classifier for this task.
Figure 6. Recall vs Accuracy for all Models
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4.6 Variable Importance
Variable importance can be easily calculated from random forest models. For the sake of
brevity, only the best model’s variable importances are shown. There are a few different
ways to look at the importance of each variable. It is important to remember that for
this model each patient’s sequence of events must be flattened so that the two-dimensional
sequence becomes one long vector. Each variable importance then is the importance of a
variable at a certain step in the sequence. The top variable importances are shown in Table
10. These are averaged over each of the five models trained during cross-validation. Since
each feature really appears a sequence length number of times in the variables, we can get
total importance for that feature by summing its importance for each sequence step. The
top variables from this method are shown in Table 11. Conversely, we can sum over all
the variable importances for each sequence step in order to see which sequence step is most
important, as shown in 12.







Attending Provider Specialty: Anesthesiology 3 0.036 0.044
Attending Provider Specialty: Nephrology 5 0.025 0.02
Attending Provider Specialty: Other 3 0.02 0.039
Procedure Code: NG tube 3 0.019 0.027
Billing Provider’s Specialty: Psychiatry 3 0.019 0.038
Diagnosis Code: Other eye dx 3 0.019 0.037
Diagnosis Code: Natural/environment 3 0.018 0.037
Diagnosis Code: Oth skin dx 4 0.018 0.036
Diagnosis Code: Other eye dx 4 0.016 0.032
Diagnosis Code: Ot dx kidney 3 0.016 0.031
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Attending Provider Specialty: Anesthesiology 0.037 0.044
Diagnosis Code: Other eye dx 0.035 0.043
Attending Provider Specialty: Nephrology 0.029 0.028
Diagnosis Code: Ot dx kidney 0.024 0.03
Attending Provider Specialty: Ambulatory Surgery Center 0.022 0.041
Attending Provider Specialty: Other 0.022 0.042
Diagnosis Code: Ot infl skin 0.021 0.029
Procedure Code: NG tube 0.019 0.027
Diagnosis Code: Natural/environment 0.019 0.036
Procedure Code: No Procedure 0.019 0.038








We also looked at which variables were the most informative for other models. Table 13
shows the variables that were on average the most important across all models.





Age at First Opioid RX Claim 0.017 0.016
Quantity of RX Claim 0.017 0.012
Procedure Code: No Procedure 0.016 0.014
Attending Provider Specialty: Other 0.015 0.016
Days Supply of RX Claim 0.015 0.017
No RX Drug Goup 0.014 0.016
Is an RX Claim 0.014 0.013
Dispensed as Written Code Blank 0.014 0.012
Diagnosis Code: No Diagnosis 0.014 0.013
Diagnosis Code: Chronic condition 0.013 0.012
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5. Discussions
The main contribution of this research is the framework laid out to extract features from
transaction data. This framework can be applied to any set of data, not just healthcare-
related data, where entities are recorded preforming events. Extracting features this way
allows machine learning models the ability to fully learn from the time-dependent aspect of
the data instead of point-in-time predictions.
This feature extraction and modeling process developed can be used to predict any event.
ORE was our chosen response in this research, but any event of interest can have be chosen.
The success of this approach is promising that the methodology might be implemented in
the real world.
5.1 Quality of Results and Implications
The extremely imbalanced nature of this data brings an added layer of difficulty in making
good predictions. The datasets on average had a 1000 to 1 ratio of negative to positive
responses. Given this, it would be very easy to have a near 100% accuracy by classifying all
patients as negative responses. Due to the nature of the response, however, it is important
to keep the false negative rate low. If a patient has any perceptible risk of an ORE they
should be flagged as such by the model as intervening for a patient is in most cases much less
costly than an ORE. To keep the false positive rate low, the metric we focus on improving
is recall, the proportion of true positives to ground-truth positives. Precision was very poor
for everyone model due to the extreme imbalance.
The best predictions made on the test set were with using the dataset with no time
aggregation. With a sequence of 10 events a LSTM network had 81.9% recall while keeping
accuracy at 79.5%. Comparatively to other research, this is a useful model. This model
will be especially useful to healthcare insurance providers. Using their data in this model
will allow them to predict with high confidence who is at the most immediate risk or an
ORE. Ideally, this model would be run for a patient every time there had a new transaction
recorded.
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The downside to this approach is the black box nature of neural networks. The impact
each variable has on the output can be calculated, but its interactions with other variables
cannot be. Other models can be interpreted more easily. Interpretation is important in the
medical field because prescribers need to know what variables to be aware of in patients
that could lead to an ORE. This model is solely good for predicting ORE likelihood given a
sequence of claims.
A shorter series of events was found to make better predictions. This is most likely due
to a couple of different reasons. Events closer to an ORE are more likely to influence the
outcome. Leaving in a large number of data points that had little to do with the ORE
since they occurred so far before that event. This extra dimensionality hindered model
performance. The greater the sequence length, the less useful information is recorded in the
data.
The sparse AE performed worse than using the original features in a classifier. This is
most likely due to the important features of the data being considered noise. Sparse AEs are
good at finding abstractions, but they also remove outliers in a set of data by smoothing all
observations to be more similar. The goal of this research is the opposite - to detect outliers.
It stands to reason that sparse AEs gave poor results.
5.2 The State of Healthcare Data
There as a data-connectivity hurdle that must be jumped on the track to more accurate
personalized healthcare. State prescription monitoring programs are a great start and lead
to life saving interventions, but they alone are not enough. Prescription history is just one
part of a patient’s medical history. Data concerning diagnoses and procedures are siloed in
separate EHR systems. Outcomes are hard to track due to this. Separate systems results in
a lack of standardization across patient records. Fast Healthcare Interoperability Resources
(FHIR) specification was developed in an attempt to standardized EHR data [72]. Higher
adoption rates of the FHIR standard will improve researchers ability to develop more accurate
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predictions. Higher data quality and connectivity will lead to a revolution in personalized
healthcare.
Data quality was detrimental to this study. Patients come in and out of the data as they
are enrolled and disenrolled in the health insurance plan. Important events may occur while
a patient is disenrolled which may have a significant impact on whether they will have an
ORE. There also could be an ORE before or after the time they appear in the data. This
is related to the issue of right-censoring of the response. Since the sequence of events for a
patient inevitably ends, either due to disenrollment or the ending of the data’s time frame,
there is an issue with right-censoring of the response. This means many of the patients
classified as negative responses actually should be labeled as positive responses.
5.3 Limitations of Research
Using Bayesian optimization to tune the hyperparameters did not yield the best results.
Many of the models trained using the hyperparameters found after 25 iterations of Bayesian
optimization predicted every observation as the majority class. It might be that more than
25 iterations are needed to tune the hyperparameters. 25 iterations is very computationally
expensive. This might have been better done using a random grid search methodology. A
smarter selection of the hyperparameter space to search might have also improved results.
Using a validation method for time series data would have been prudent. Walkforward
validation is one of the simplest. In this method, a patient would have a sequence of events
created for each time step. This was not done due to the size of the data.
Using a smaller subset of patients may have been a better technique. A smaller cohort
would have sped up computation times and possibly led to a more accurate model. In a
similar vein, stratifying the cohort based on different demographics and training a separate
model for each strata might have yielded more accurate results as well.
Even the best model found is not well calibrated. Though not included in this paper,
the calibration curve (sometimes referred to as a reliability plot) is very poor. A majority
of test set predictions for positive responses are around 0.5, with no observations around 0
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or 1. Even though a threshold was found that showed relatively good accuracy and recall,
the model needs to be calibrated. Both Platt’s scaling [73] and isotonic regression [74] are
common calibration techniques that could improve the model. Temperature scaling is a
simple variant of Platt’s scaling that has been shown to work well for neural networks [75].
5.4 Future Work
While the results are very good, it does not mean that the best strategy for modeling this
data has been found. There are several strategies that still need to be investigated to improve
results further.
Variable length time windows may provide better results in certain situations. In partic-
ular, using an expanding time windows that get larger for events further in the past may be
useful. This research only focused on fixed length time windows and it would be interesting
to see if predictions could be improving by varying the sizes of the windows.
Patient data was static throughout the sequence of events for each patient. There is no
reason to input static data into a RNN; FNNs are much more appropriate for handling data
that is not sequence dependent. It might give better results to separate static and event data,
train a FNN using the static and a RNN using events, then ensemble the two. Similarly, it
may help to split up events. We treated every event as equal in this research. In reality this
is not the case. There is a reason the data was broken up into prescription, inpatient, and
outpatient event tables. We could keep these tables separate, train and model for each, and
ensemble the resulting models.
Combining the sparse AE and RNN methods by adding a few layers of sparsity before
the recurrent layers might improve results as well. Training them at the same time might
have more computational expense, but could generate better results. Similarly, we could use
a supervised learning approach to train the AE alone before combining the models. In this
method a final output layer would be added to the AE for training, so that it would be a
prediction model minimizing a log loss function. Both of these methods are opposed to the
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previous unsupervised approach in which the goal of training was to minimize mean squared
error between the input and output sequences.
Given the success of the methodology, it should be used for predicting a number of
other healthcare events using the same data. The methodology should be used with other
transaction data as well to test the how well it generalizes to other domains.
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